Spain's benchmark stock index, the IBEX 35, closed Friday's session with a strong 1.65% gain, driven by broad-based advances in the financial services and consumer sectors. Steelmaker Acerinox was the standout performer, surging over 10% to a five-year high.
The U.S. Food and Drug Administration has greenlit a new over-the-counter pain relief pill from Kenvue combining Tylenol and naproxen. The approval comes as Kenvue navigates a multi-billion dollar acquisition by Kimberly-Clark and ongoing Tylenol-related litigation.
Portugal's benchmark stock index, the PSI, ended Friday's session down 0.40%, pulled lower by significant declines in heavyweight stocks like Galp Energia and Nos SGPS amid a sharp drop in global oil prices.
Lightspeed Commerce saw its stock climb after launching a new tool that integrates its retail point-of-sale system with Meta's ad platform, enabling physical stores to track offline sales driven by digital campaigns.
Shares of Radiopharm Theranostics dropped sharply after the clinical-stage biopharmaceutical company announced a plan to raise up to $13 million through a discounted offering of shares and warrants, diluting existing shareholder value.
The UK's benchmark stock index gained 0.93% to close at a new three-month high on Friday, propelled by strong performances in the software, aerospace, and media sectors.
The cloud infrastructure provider's stock fell after it announced a deal to buy back a significant portion of its 2030 convertible notes, funded by a concurrent offering of common stock to the noteholders.
The chipmaker's stock reversed gains to close lower after a report revealed it plans double-digit percentage price increases on its products, citing rising supplier costs.
Yacht retailer MarineMax is reportedly in the final stages of a sale process, with investment firms Blackstone and Donerail among the last remaining bidders, according to sources familiar with the matter. The potential acquisition follows months of pressure from activist investors.
